Accipiter Biosciences · Seed

AI-designed de novo protein therapies for complex diseases

Amount

$12.7M

Round

Seed

Valuation

—

Announced

Nov 2025

Investors

Lead investor

Flying Fish Partners

Participating investors

Takeda Lead Columbus Venture Partners Argonautic Ventures Cercano Capital Washington Research Foundation Alexandria Investments Pack Ventures